Lilly continues to sweep court rulings regarding Alimta patent 12-Aug-2019 By Maggie Lynch Courts continue to rule in favor of Lilly’s lung cancer treatment patent, as the District Court for Appeals concludes generic producers like Dr Reddy’s to be potentially infringing.
FDA issues second Form 483 on Dr Reddy’s India plant 05-Aug-2019 By Vassia Barba Dr Reddy’s receives a Form 483 with five observations, regarding customer complaints for out-of-specifications results of APIs.